Pediatric Cancer Treatment Drugs Market - Top Companies and Manufacturers

Companies Dominating the Pediatric Cancer Treatment Drugs Landscape

Bristol Myers Squibb Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Epizyme, Inc.
Eisai Co., Ltd.
Recordati Rare Diseases Inc.
Merck & Co., Inc.
Novartis AG
Leadiant Biosciences
EUSA Pharma, Inc.
Jazz Pharmaceuticals plc
Amgen Inc.

Browse Key Market Insights with Data Illustration:

Pediatric Cancer Treatment Drugs Market Size & Share | Forecast Report 2036

In the News

August 2021- Epizyme and HUTCHMED announced a strategic collaboration for the development and commercialization of TAZVERIK, a drug for treating pediatric cancers, in Greater China.
April 2021- Amgen’s BLINCYTO demonstrated prolonged event-free survival as compared to consolidation chemotherapy in pediatric patients suffering from relapsed acute lymphoblastic leukemia.

Frequently Asked Questions (FAQ)

Pediatric Cancer Treatment Drugs Market size is poised to witness lucrative growth rate during the forecast period i.e., between 2024-2036.

The market growth is driven by increasing occurrence of cancer among children, and rising prevalence of childhood obesity worldwide.

Asia Pacific industry is poised to dominate majority revenue share by 2036, ascribed to increasing government investments to enhance the medical infrastructure, and rising awareness about different treatment options in pediatric oncology.

The major players in the market are Bristol Myers Squibb Company, Epizyme, Inc., Eisai Co., Ltd., Recordati Rare Diseases Inc., Merck & Co., Inc., and others.

Pediatric Cancer Treatment Drugs Market - Top Companies and Manufacturers

Companies Dominating the Pediatric Cancer Treatment Drugs Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the pediatric cancer treatment drugs market?

What are the factors driving the pediatric cancer treatment drugs landscape?

Which region held the largest pediatric cancer treatment drugs industry share?

Who are the key players in the pediatric cancer treatment drugs sector?